SCHEMBL862422

SCHEMBL862422

Cn1c(C(=O)NS(=O)(=O)c2cccc(NS(C)(=O)=O)c2)c(-c2ccc[nH]c2=O)c2cc(Cl)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.39
HPGD P15428 1/20 0.39
TDP2 O95551 1/20 0.38
FLT1 P17948 7/20 0.37
FLT4 P35916 7/20 0.37
KDR P35968 7/20 0.37
PKM P14618 3/20 0.36
MCL1 Q07820 1/20 0.36
HTT P42858 1/20 0.36
FBP1 P09467 3/20 0.34
LMNA P02545 2/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
EGFR P00533 1/20 0.34
TAS2R14 Q9NYV8 1/20 0.34
PPARG P37231 1/20 0.34
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL862257 0.90 KDM4E (0.39) ALDH1A1KDM4ECYP1A2HPGDFLT1
SCHEMBL862443 0.90 TDP2 (0.36) ALDH1A1KDM4ECYP1A2HPGDTDP2
SCHEMBL862476 0.89 PPARG (0.36) ALDH1A1KDM4ECYP1A2HPGDTDP2
SCHEMBL862296 0.88 PPARG (0.41) TDP2MCL1MEN1KMT2APPARG
SCHEMBL862372 0.88 ALDH1A1 (0.41) ALDH1A1KDM4ECYP1A2HPGDFLT1
SCHEMBL832354 0.87 PPARG (0.38) ALDH1A1KDM4ECYP1A2HPGDTDP2
SCHEMBL10257021 0.87 PPARG (0.39) ALDH1A1KDM4ECYP1A2HPGDTDP2
SCHEMBL862329 0.87 PPARG (0.40) TDP2FLT1FLT4KDRPKM
SCHEMBL862454 0.86 CYP2C8 (0.39) TDP2FLT1FLT4KDRMAPT
SCHEMBL862488 0.86 SERPINE1 (0.38) TDP2FLT1FLT4KDRMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143305-B2 2,3-substituted indole derivatives for treating viral infections SCHERING CORPORATION (US) 2012-03-27 US disclosed
US-20110033417-A1 2,3-SUBSTITUTED INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS MERCK SHARP & DOHME CORP. 2011-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110033417-A1 2,3-SUBSTITUTED INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS IDO2, IDO1, IRF3 ALDH1A1 1792/4885KDM4E 1061/4885CYP1A2 305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.